CIC BiomaGUNE
Centro (uo)
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (5)
2009
-
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET
NeuroImage, Vol. 46, Núm. 2, pp. 447-458
2006
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1 - Pseudoequilibrium interval and quantification methods
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 919-928
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 2 - Ketanserin displacement
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 929-937
2005
-
SPECT of serotonin transporters using123I-ADAM: Optimal imaging time after bolus injection and long-term test-retest in healthy volunteers
Journal of Nuclear Medicine, Vol. 46, Núm. 8, pp. 1301-1309
1999
-
Magnetic resonance imaging in the evaluation of inflammatory lesions in muscular and soft tissues: An experimental infection model induced by Candida albicans
Magnetic Resonance Imaging, Vol. 17, Núm. 9, pp. 1327-1334